Familial Chylomicronemia Syndrome in Children: a Diagnosis Challenge

Overview

Journal Transl Pediatr

Publisher AME Publishing Company

Specialty Pediatrics

Date 2022 Dec 12

PMID 36506766

Authors

Maria Jose Ariza

Pedro Valdivielso

Affiliations

Soon will be listed here.

Citing Articles

An unusual case of type I hyperlipidemia - infant with acute encephalopathy, bulging fontanel, vomiting and pink blood: a case report.

Kalanj J, Cobeljic M, Jesic M, Zdravkovic V, Cvetkovic M, Vukasinovic N BMC Pediatr. 2024; 24(1):815.

PMID: 39696078 PMC: 11656882. DOI: 10.1186/s12887-024-05287-9.

Clinical and molecular characterization of familial chylomicronemia in Saudi patients: a retrospective study.

Al-Ashwal A, AlHelal M, Alsagheir A, AlFattani A, Ramzan K, Imtiaz F Front Endocrinol (Lausanne). 2024; 15:1439862.

PMID: 39619325 PMC: 11605512. DOI: 10.3389/fendo.2024.1439862.

Diagnosis and stabilisation of familial chylomicronemia syndrome in two infants presenting with hypertriglyceridemia-induced acute pancreatitis.

Heath O, Allender B, Smith J, Savva E, Spencer L, Bannister E JIMD Rep. 2024; 65(4):239-248.

PMID: 38974610 PMC: 11224501. DOI: 10.1002/jmd2.12434.

Hyperlipidemia and Cardiovascular Risk in Children and Adolescents.

Mainieri F, La Bella S, Chiarelli F Biomedicines. 2023; 11(3).

PMID: 36979789 PMC: 10045454. DOI: 10.3390/biomedicines11030809.

References

Eguchi J, Miyashita K, Fukamachi I, Nakajima K, Murakami M, Kawahara Y . GPIHBP1 autoantibody syndrome during interferon β1a treatment. J Clin Lipidol. 2018; 13(1):62-69. PMC: 6379125. DOI: 10.1016/j.jacl.2018.10.004. View

Merker V, Slobogean B, Jordan J, Langmead S, Meterko M, Charns M . Understanding barriers to diagnosis in a rare, genetic disease: Delays and errors in diagnosing schwannomatosis. Am J Med Genet A. 2022; 188(9):2672-2683. PMC: 9378587. DOI: 10.1002/ajmg.a.62860. View

Li Y, Hu M, Han L, Feng L, Yang L, Chen X . Case Report: Next-Generation Sequencing Identified a Novel Pair of Compound-Heterozygous Mutations of Gene Causing Lipoprotein Lipase Deficiency. Front Genet. 2022; 13:831133. PMC: 8927541. DOI: 10.3389/fgene.2022.831133. View

Thajer A, Skacel G, de Gier C, Greber-Platzer S . The Effect of a Fat-Restricted Diet in Four Patients with Familial Chylomicronemia Syndrome: A Long-Term Follow-Up Study. Children (Basel). 2021; 8(11). PMC: 8619212. DOI: 10.3390/children8111078. View

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J . Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015; 17(5):405-24. PMC: 4544753. DOI: 10.1038/gim.2015.30. View

Beliard S, Di Filippo M, Kaplanski G, Valero R . Highly efficacious, long-term, triglyceride lowering with rituximab therapy in a patient with autoimmune hypertriglyceridemia. J Clin Lipidol. 2018; 12(4):883-887. DOI: 10.1016/j.jacl.2018.04.011. View

Ariza M, Rioja J, Ibarretxe D, Camacho A, Diaz-Diaz J, Mangas A . Molecular basis of the familial chylomicronemia syndrome in patients from the National Dyslipidemia Registry of the Spanish Atherosclerosis Society. J Clin Lipidol. 2018; 12(6):1482-1492.e3. DOI: 10.1016/j.jacl.2018.07.013. View

Shi H, Wang Z . Novel pathogenic variant combination in causing familial chylomicronemia syndrome in an Asian family and experimental validation : a case report. Transl Pediatr. 2022; 11(10):1717-1725. PMC: 9636460. DOI: 10.21037/tp-22-15. View

Rioja J, Ariza M, Garcia-Casares N, Coca-Prieto I, Arrobas T, Muniz-Grijalvo O . Evaluation of the chylomicron-TG to VLDL-TG ratio for type I hyperlipoproteinemia diagnostic. Eur J Clin Invest. 2020; 50(12):e13345. DOI: 10.1111/eci.13345. View

10.

Witztum J, Gaudet D, Freedman S, Alexander V, Digenio A, Williams K . Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome. N Engl J Med. 2019; 381(6):531-542. DOI: 10.1056/NEJMoa1715944. View

11.

Levy E, Godard M, Lambert M . Familial lipoprotein lipase deficiency in infancy: clinical, biochemical, and molecular study. J Pediatr. 1998; 133(3):417-23. DOI: 10.1016/s0022-3476(98)70280-x. View

12.

Navarro Hermoso A, Valdivielso P . Treatment of chylomicronemia. Clin Investig Arterioscler. 2021; 33 Suppl 2:75-79. DOI: 10.1016/j.arteri.2021.01.004. View

13.

Lippi G, Plebani M, Favaloro E . Interference in coagulation testing: focus on spurious hemolysis, icterus, and lipemia. Semin Thromb Hemost. 2012; 39(3):258-66. DOI: 10.1055/s-0032-1328972. View

14.

Wilson D, Williams L, Kavey R . Hypertriglyceridemia in Youth. J Pediatr. 2021; 243:200-207. DOI: 10.1016/j.jpeds.2021.12.017. View

15.

Castro-Castro M, Candas-Estebanez B, Esteban-Salan M, Calmarza P, Arrobas-Velilla T, Romero-Roman C . Removing Lipemia in Serum/Plasma Samples: A Multicenter Study. Ann Lab Med. 2018; 38(6):518-523. PMC: 6056396. DOI: 10.3343/alm.2018.38.6.518. View

16.

Guardiola M, Ibarretxe D, Plana N, Masana L, Ribalta J . DNA methylation pattern of hypertriglyceridemic subjects. Clin Investig Arterioscler. 2021; 34(1):27-32. DOI: 10.1016/j.arteri.2021.09.002. View

17.

Hegele R, Dron J . 2019 George Lyman Duff Memorial Lecture: Three Decades of Examining DNA in Patients With Dyslipidemia. Arterioscler Thromb Vasc Biol. 2020; 40(9):1970-1981. DOI: 10.1161/ATVBAHA.120.313065. View

18.

Rodrigues R, Artieda M, Tejedor D, Martinez A, Konstantinova P, Petry H . Pathogenic classification of LPL gene variants reported to be associated with LPL deficiency. J Clin Lipidol. 2016; 10(2):394-409. DOI: 10.1016/j.jacl.2015.12.015. View

19.

Chokshi N, Blumenschein S, Ahmad Z, Garg A . Genotype-phenotype relationships in patients with type I hyperlipoproteinemia. J Clin Lipidol. 2014; 8(3):287-95. DOI: 10.1016/j.jacl.2014.02.006. View

20.

Rahalkar A, Giffen F, Har B, Ho J, Morrison K, Hill J . Novel LPL mutations associated with lipoprotein lipase deficiency: two case reports and a literature review. Can J Physiol Pharmacol. 2009; 87(3):151-60. DOI: 10.1139/y09-005. View